Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Returns
Return on equity-627.1%
Return on assets-570.1%-246pp-491.3%+291pp-60.4%+608pp-46.4%+455pp-324.3%+416pp
Liquidity
Current ratio13.9×+11.5×1.7×+1.5×0.1×-0.4×-0.8×2.4×+2.2×
Quick ratio13.9×+11.5×1.7×+1.5×0.1×-0.4×-0.8×2.4×+2.2×
Cash ratio2.1×-0.1×0.5×+0.4×0.1×-0.3×-0.7×2.2×+2.1×
Per Share
Book value per share$0.91+627%$2.78+2,624%-$0.21-735%-$0.13-26,000%$0.13+129%
Valuation
Market capitalization$88.66M-61.8%$123.64M+381%$203.16M+4,526%$1.13B+24,967%$14.31M+132%
Price / book0.6×0.9×5.5×
Earnings yield-571.4%-560pp-374.3%-334pp-19.6%+328pp-2.3%+394pp-68.1%+339pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are BioSig Technologies, Inc.'s profit margins?
BioSig Technologies, Inc. (STEX) runs a 80.1% gross margin and a -32155.0% operating margin, with a -25825.0% net margin.
Where do BioSig Technologies, Inc.'s ratios come from?
Every ratio is computed from BioSig Technologies, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.